A Phase 1/2 Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Carfilzomib (Primary) ; Dexamethasone; Dexamethasone
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- Acronyms CHAMPION-1
- Sponsors Amgen; Onyx Pharmaceuticals
- 11 Jul 2017 Planned End Date changed from 1 Jun 2017 to 31 Dec 2017.
- 14 Mar 2017 Planned End Date changed from 1 Mar 2017 to 1 Jun 2017.
- 01 Mar 2017 Data will be presented at at the 16th International Myeloma Workshop (IMW), according to an Amgen media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History